Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction

Clinical trial NCT04383262 · RECRUITING

Trial details

NCT number: NCT04383262
Sponsor: Medical College of Wisconsin
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Laryngopharyngeal Reflux

Start date: 2026-07-15
Primary completion: 2027-07-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.